chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my heart felt like it was beating out of my chest; BP was very high; heart was gonna pound out of her chest; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), administration date 12Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing), notes: She has had high blood pressure before and is on medication for it. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose no:1, 1st one was in Mar2021.), administration date: Mar2021, for COVID-19 Immunization. The following information was reported: HEART RATE INCREASED (non-serious) with onset 27Sep2021 01:00, outcome "unknown", described as "my heart felt like it was beating out of my chest"; BLOOD PRESSURE INCREASED (non-serious) with onset 27Sep2021 01:00, outcome "unknown", described as "BP was very high"; PALPITATIONS (non-serious) with onset 27Sep2021 01:00, outcome "recovered", described as "heart was gonna pound out of her chest". The events "my heart felt like it was beating out of my chest", "bp was very high" and "heart was gonna pound out of her chest" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heart rate increased, blood pressure increased, palpitations.  Additional information- Patient states that she has had both of the Pfizer shots, the last one was on 12Apr2021, and the 1st one was in Mar2021. She clarified the product as the Pfizer Covid 19 Vaccine. States that several months after getting the 2nd shot she woke up at 1am and felt like her heart was gonna pound out of her chest, but her blood pressure was through the roof also. Her doctor said that she needs to get the booster, but she was a little leery of getting it now. States that she had the pounding heart, but it may not have been from the vaccine. She has had high blood pressure before and was on medication for it. She is reading that myocarditis and pericarditis has been found in children after receiving the vaccine, but she is 74 years old, so she doesn't know if it's been found in her age group, and the pounding heart only happened the one time.She states that they put her on a low dose of another blood pressure medication after it happened, though she doesn't know that she really needs it.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient woke with injection site erythemic, edematous, warm, and about an area of 5cm square. No respiratory distress, angioedema, fever, pain with ambulation, or exudate oozing from area.
got the flu; pericarditis symptoms began on week of 09Oct2023; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 47-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 29Sep2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 29Sep2023 as dose number unknown, single (Batch/Lot number: unknown) for influenza immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERICARDITIS (hospitalization) with onset 09Oct2023, outcome "recovering", described as "pericarditis symptoms began on week of 09Oct2023"; INFLUENZA (hospitalization) with onset 17Oct2023, outcome "recovering", described as "got the flu". The patient was hospitalized for pericarditis, influenza (start date: 25Oct2023, discharge date: Oct2023, hospitalization duration: 3 day(s)). Therapeutic measures were taken as a result of pericarditis, influenza. Clinical Course: Patient had treatment with pills exact type unknown.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
2 hours after injection received headache and body ache. Next day had fever of 99.9 and nausea.  Went to MD and the MD said must be a reaction to the vaccine.
lost hearing in one ear; This is a spontaneous report from a non-contactable consumer. A 60-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After the second Pfizer COVID vaccine, patient was in bed for 3 days, and lost hearing in one ear about 3-4 days after the shot. Doctor put him on steroids. ENT said that for people who had COVID the cytokine release could be very damaging to the auditory nerve. It's been about a week since the hearing loss and he has not yet recovered.  No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.
Information has been received from a registered nurse concerning a 7 year old female with exercise induced asthma and no known allergies, who on 20-SEP-2002 and 08-APR-2008 was vaccinates subcutaneous with a first and second 0.5 ml dose of VARIVAX (Oka/Merck) (lot # 659698/1770U 2nd dose). Concomitant therapy included Albuterol and HAVRIX (GSK - LOT# AHAVB2250A). There was no reported illnesses at the time of the vaccinations. On 26-ARP-2008 the patient developed a rash that started on the face, neck and chest. There were skin vesicles with surrounding erythema with less than 50 lesions. The patient presented to the physician's office on 28-APR-2008 with the chickenpox. Subsequently, the patient recovered from chickenpox. The reporter requested a lot check on (lot # 659698/1770U). A standard lot check investigation was performed. All in process quality checks for the lot number in question were satisfactory. The lot met the requirements of the agency and was released. This is one of several reports received from the same source. Additional information is not expected.
after 2nd dose, coughing was completely gone.; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (after 2nd dose, coughing was completely gone.) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Coughing (Excessive coughing since 2 years).   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after 2nd dose, coughing was completely gone.). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (after 2nd dose, coughing was completely gone.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided.
30 minutes after injection given patient started to complain of a bad taste in her mouth; describing a soapy taste; lasted rest of day. Next day taste gone.
Several weeks after vaccination, had mild cough, fatigue, and fever whenever tired, usually at night. Cough and night sweats still recurring when fatigued 5 weeks after vaccination.
On the night of 2nd vaccine dose, I got an allergic reaction like the first time. I woke at 3am with severe itching all over my body, no visible rash. Instead of visiting a facility like with my first dose/reaction, I toughed this one out at home and immediately took otc allergy pills. The itching ended after 14 hours at 5pm that day.
Presents to HS c/o tenderness, swelling and itching LUA where Tdap had been given 11/21/06. States she hasn't noticed any redness or swelling LUA until yesterday afternoon, but has experienced localized tenderness at site since injection. States she was sitting out in the sun yesterday afternoon at the time she noticed it. States she took Benadryl. Site examined. Slight induration and erythema measuring 11 cm long and 8 cm across at or near injection site. Warm to touch.
Headache, 103 fever, aches, chills, diarrhea, vomiting, vertigo, panick attack. Started 5/14 through 5/18. Took Theraflu and powdered electrolytes from BioPure.
My daughter received the MMR on March 29th, 2003.  About 7 days later she started bruising.  For the next several weeks it got worse.  Bruising to the head, face, back, and legs.  A rash developed, but the pediatrician was not to concerned.  Took her in to she the pediatrician on April 21, 2003 and she sent me to hospital to have her blood checked.  She had acute ITP.  She received treatment (WhinRho) and goes to see the hemotologist every 2 weeks to get a platelet count.
Within the hour after receiving shot, migraine formed along with fatigue. Both progressively got worse through out that day(4/7/21). On 4/8/21 I woke up many times through out the night with a migraine that felt as though my brain was burning and sinus pressure, causing immense eye sensitivity. Throughout the night I became increasingly more sweaty, but didn?t have the proper thermometer to take my temperature.  I took ibuprofen (at 6:45 AM on 4/8/21) which helped those two side effects subside (around 8 AM). Fatigue has been constant throughout both days. Around 5:00 PM on 4/8/21 I ate broccoli and rice for dinner, small amounts, and encountered bad diarrhea. It lasted for about half an hour. Migraine is reduced significantly (at 6:41 PM), but there is slight nausea, weakness, and fatigue.
10 days after vaccination developed an erythematous, raised rash that was warm to the touch.  Lasted approximately 4 days.
I am having adverse reactions to the vaccine. My head and whole body aches as if I have the flu, or worse. I had cold shooting pains from the vaccine site up to my neck and chest, etc. Short sharp pains in my chest and hips. I had to call in sick for work today.
Severe swelling in immunized arm. Advised her to use ice pack, and BENADRYL if needed. If size didn't decrease, seek medical attention at walk in clinic.
This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a 59-year-old male patient who received SHINGRIX (batch number D3L5G, expiry date 29th November 2020) for prophylaxis. The patient's past medical history included arthritis. On 23rd July 2018, the patient received SHINGRIX (intramuscular). On 24th July 2018, 1 days after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The health care professional reported that patient experienced flu like symptoms beginning the day after receipt of the vaccine and the symptoms lasted for a day or 2 then resolved. The patient received vaccine on left deltoid. This was 1 of the 4 linked cases reported by the same reporter.
PATIENT CALLED ME INFORMING ME WIFE NOTICED SEMI-HARD WELT AT SITE OF INJECTION. i QUESTIONED PATIENT ABOUT POSSIBLE ANAPHYLACTIC  REACTION- SWELLING LIPS, SWELLING TONGUE, WELTS, HIVES OR DIFFICULTY BREATHING. PATIENT STATED HIS REACTION WAS ONLY LIMITED TO INJECTION SITE.  I INFORMED HIM TO TREAT WITH ICE AND 50MG OF BENADRYL 2 TO 3 TIMES DAILY.
Arm started sore then after a few hours felt drained.  By 6:30 pm had head ache and muscle aches  took hot shower then went to sleep.  Sleep for about 14 hours then.  Still feel pain in my arm and muscles  but also now have low grade fever even after taking tylenole at 10:15 am  at 12:20 pm 99.9 degrees also have headache
2 or 3 days after first shot, I noticed my face drooping a bit on the left side of my mouth. then my left eye would not open imediately when would wake up. 2 days after my 2nd muscle weakness worsened; 2 or 3 days after first shot, I noticed my face drooping a bit on the left side of my mouth. then my left eye would not open imediately when would wake up. 2 days after my 2nd muscle weakness worsened; 2 or 3 days after first shot, I noticed my face drooping a bit on the left side of my mouth. then my left eye would not open imediately when would wake up. 2 days after my 2nd muscle weakness worsened; This is a spontaneous report from a contactable consumer (patient).  A 51-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 03Apr2021 12:15 (Batch/Lot Number: EP6955) as SINGLE DOSE, patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  via an unspecified route of administration, administered in Arm Left on 24Apr2021 12:30 (Batch/Lot Number: ER8735) as SINGLE DOSE for covid-19 immunisation. Medical history included hypertension, stroke after surgery (No lasting effects from stroke). Relevant past drug history: known drug hypersensitivity to Sulfa drugs. Concomitant medications included lisinopril (LISINOPRIL),  atorvastatin (ATORVASTATIN), gabapentin (GABAPENTIN),  loratadine (LOTADINE). No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19 On an unspecified date Apr2021,The patient experienced Bells Palsy, Facial droop, muscle weakness worsened.. The clinical course was reported as follows 2 or 3 days after first shot, patient 'I  noticed  face drooping a bit on the left side of my mouth. then my left eye would not open immediately when would wake up. 2 days after my 2nd muscle weakness worsened. The events were medically significant. The adverse events did required an Emergency Room Visit. Therapeutic measures were taken as a result of Bells Palsy, Facial droop , muscle weakness worsened. The clinical outcome of the events was recovering.    Follow up needed, further information has been requested.
Vomiting, diarrhea,  fever, generalized intense pain. Fatigue still experiencing at this time
Injection site pain started approx 4.5hrs after shot (administered at 1:30pm on Tues.)Cold to the bone chills approx 3am Wends. Woke up fatigued, slightly nauseous, no appetite, light sensitive migraine, pain in all joints, muscle pain (8am Weds.). All above side effects continued to worsen through the morning.  At 11:45am I got into bed and aside from getting more water to drink and bathroom breaks, I stayed there until Thurs. morning 8am. Thurs. chills were gone.  Migraine, joint and muscle pain subsided, but still had a slight headache. Nausea decreased enough to bring back appetite. Headache gone approx 11am. Fatigued continued until approx 5pm Thurs.
Patient presented with localized swelling and redness of left upper arm. Warm to the touch. Asked if there was any loss of mobility or any pain and she said no. She did say that she feels like she's more forgetful since the vaccination. She said she forgot where she parked her car after receiving the shot.
pt recv vax 7/22/97 & pt preg;pt exp endometritis during labor;pt exp an infect from chorioamnionitis;
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 12-JUL-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 5 microgram/0.5ml (thimerosal free, lot # L008660, expiration date 10-NOV-2016. No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 920, 34 and R; 168, 32 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
fever/ low grade fever; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever/ low grade fever) in a 56-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. AU3834B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer (First Monovalent Booster dose) on 21-Oct-2021 and Pfizer (Monovalent Booster dose) on 08-Sep-2022. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 04-Nov-2023 at 11:30 AM, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 05-Nov-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced PYREXIA (fever/ low grade fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency and CAFFEINE, CODEINE PHOSPHATE, PARACETAMOL, PIPERYLONE MALEATE (THERAFLU [CAFFEINE;CODEINE PHOSPHATE;PARACETAMOL;PIPERYLONE MALEATE]) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever/ low grade fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2023, Body temperature: 100 F.         Concomitant medication not reported.   On Sunday 05 NOV 2023 he started having a low-grade Fever 100 F. He took some Ibuprofen and Theraflu. The fever goes away, he sleeps and waking up the fever was back. He drunk a lot of water. His fever not gone over 100 Fahrenheit. He has been having a low-grade fever on and off.   First Primary Moderna monovalent dose on 07 Feb 2021 with unknown with lot number and expiry date.  2nd Primary Moderna monovalent dose on 5 Mar 2021 with unknown with lot number and expiry date. Dose 5 Moderna Bivalent Booster on 23 Aug 2023 (Lot number AS7643E and Expiry Date with unknown). Dose 6 of Spikevax by Moderna on 04 Nov 2023 (Lot number AU3834B and Expiry Date with unknown).
Pt recvd vax & devel hives; both instances was treated w/Antihistamines & the hives resolved;
Day of and following day of first shot was fatigue, slight chills, intermittant headache. After 48 hrs severe joint pain in my shoulders, predominantly the left - sites of previous and ongoing damage. Also severe swelling and joint pain in the toes of my right foot, also a site of a previous and ongoing issue. Excema: a skin rash, that is an autoimmune  reaction to stress, returned around my mouth These side effects lasted for most of the first week following the first shot. Abating considerably by day 6
Within 2-3 minutes she felt sick and dizzy, then became clammy and unresponsive. She was moved to the floor and regained consciousness within 1 minute. Was given water and a snack and felt better. She left happy and healthy, she does not like needles/vaccination - so she had anxiety from the vaccine.
This spontaneous report as received from a Registered Nurse refers to a 14 year old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. On an unspecified date in August 2014, the patient was vaccinated with the first dose of GARDASIL, intramuscular (lot number and expiration date were not provided). The patient received a second dose on 10-MAR-2015 and a third one on 10-APR-2015, both of GARDASIL, intramuscular (lot number and expiration date were not provided). No concomitant therapies were reported, neither was any adverse effect. Additional information has been requested.